Missed this webinar? Click here to purchase the recording.

Significant changes to Patented Medicines (Notice of Compliance) Regulations came into force on September 21, 2017. Pursuant to obligations under CETA, to end dual litigation and provide a right of appeal, these amendments will have a major impact on the courts and those who litigate pharmaceutical patents in Canada.

In this webinar, expert patent litigators will examine the new Regulations' substantive and procedural changes affecting both brand and generic sides of the pharmaceutical industry.


Carol Hitchman Sprigings Intellectual Property Law

Yael Bienenstock Torys LLP


Paul Lomic Lomic Law

Registration Fees

1-2 people: $149
3-5 people: $299
6 or more people: $499

Non Member
1-2 people: $199
3-5 people: $349
6 or more people: $549





Financial aid may be available to participate in this webinar. Applicants will be considered on the basis of their annual income. Inquiries:


Participants will view the webinar’s presentation online and hear the presenters by phone or through the computer. A web link and audio coordinates will be provided to the registrant the day before the webinar.

Group Participation

Group participation is possible provided that only one phone line is used to join the audio. Therefore, you may not register a group if participants are in separate locations.

Continuing Professional Development

This program is eligible for up to 1 Substantive Hour.


1 hr

Law Society of Upper Canada

Barreau du Québec

Law Society of British Columbia

Law Society of Saskatchewan

upon request

Law Society of Manitoba

Law Society of Alberta

New York CLE Board